Does TISLELIZUMAB Cause Hyperthyroidism? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Hyperthyroidism have been filed in association with TISLELIZUMAB (TEVIMBRA). This represents 0.3% of all adverse event reports for TISLELIZUMAB.
17
Reports of Hyperthyroidism with TISLELIZUMAB
0.3%
of all TISLELIZUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hyperthyroidism From TISLELIZUMAB?
Of the 17 reports, 4 (23.5%) required hospitalization.
Is Hyperthyroidism Listed in the Official Label?
Yes, Hyperthyroidism is listed as a known adverse reaction in the official FDA drug label for TISLELIZUMAB.
What Other Side Effects Does TISLELIZUMAB Cause?
Myelosuppression (2,142)
White blood cell count decreased (327)
Neutrophil count decreased (277)
Hepatic function abnormal (221)
Pruritus (213)
Rash (208)
Platelet count decreased (183)
Pyrexia (175)
Nausea (165)
Diarrhoea (145)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
Which TISLELIZUMAB Alternatives Have Lower Hyperthyroidism Risk?
TISLELIZUMAB vs TISOTUMAB VEDOTIN
TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV
TISLELIZUMAB vs TITANIUM DIOXIDE\ZINC
TISLELIZUMAB vs TIVICAY
TISLELIZUMAB vs TIVOZANIB